Invasive Hemodynamic and Vasoreactivity Testing with Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Defects
Objective:. Invasive hemodynamic evaluation and acute vasoreactivity testing are recommended in the diagnosis of pulmonary arterial hypertension (PAH), but their clinical role in children with PAH associated with congenital heart defects (CHD) is unclear. This study aims to investigate acute hemodyn...
Saved in:
| Main Authors: | Qiangqiang Li, Yuan He, Chen Zhang, Hong Gu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-12-01
|
| Series: | Cardiology Discovery |
| Online Access: | http://journals.lww.com/10.1097/CD9.0000000000000109 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
by: A. A. Shmalts, et al.
Published: (2022-10-01) -
CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIES
by: V. M. Paramonov, et al.
Published: (2016-03-01) -
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension
by: Goncharova Natalia, et al.
Published: (2025-01-01) -
Experience with Inhaled Iloprost Used in the Surgical Treatment of Chronic Postthromboembolic Pulmonary Hypertension
by: V. V. Lomivorotov, et al.
Published: (2013-04-01) -
Pediatric Use of Inhaled Iloprost
by: Stephanie S. Handler, et al.
Published: (2025-04-01)